4//SEC Filing
Adaptimmune Therapeutics PLC 4
Accession 0001104659-16-139406
$ADAPCIK 0001621227operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 6:20 PM ET
Size
5.5 KB
Accession
0001104659-16-139406
Insider Transaction Report
Form 4
Knowles Jonathan Kenneth Charles
Director
Transactions
- Award
Option to purchase Ordinary Shares
2016-08-11+217,222→ 217,222 totalExercise: $1.27From: 2017-08-11Exp: 2026-08-11→ Ordinary Shares (217,222 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.97 based on the closing midpoint exchange rate for the U.S. dollar on the day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 6:20 PM ET
- Size
- 5.5 KB